Leukemia bruises in infants are caused mainly by a low platelet count, because leukemia cells crowd the bone marrow and suppress normal platelet production. The bruises tend to appear without a clear injury, in unusual places, and alongside other signs such as pallor, tiny red spots (petechiae), fever, poor feeding, or an enlarged liver and spleen. Any unexplained bruise in a baby who is not yet crawling or cruising warrants a same-day clinical assessment and a complete blood count.
Leukemia in the first year of life is rare, and most bruises in babies have other explanations. This guide, written for clinicians and informed parents alike, covers why leukemia in infants causes bruising, how to separate it from other causes, and how the diagnosis is confirmed.
Why Leukemia Causes Bruising in Babies
In leukemia, immature white cells called blasts multiply uncontrollably in the marrow. They displace the megakaryocytes that produce platelets, so platelet production falls. The result is thrombocytopenia, a low platelet count, and the blood’s first line of defense against bleeding weakens.
Bruising may also reflect clotting abnormalities. Some leukemias, particularly certain myeloid types, can trigger disseminated intravascular coagulation (DIC), in which clotting factors are consumed. In infants, leukemia cells can also infiltrate the skin directly, a finding called leukemia cutis, producing bluish or purple nodules that are easily mistaken for bruises. The classic “blueberry muffin” appearance in a newborn has several causes, and congenital leukemia is one of them.
Recognizing the Clinical Picture
Infant leukemia tends to present more aggressively than leukemia in older children. Bruising is rarely the only sign. Look for a cluster of findings:
- Petechiae, pinpoint red or purple spots that do not blanch under pressure
- Ecchymoses (bruises) on the trunk, back, face, or other areas that are not usually bumped
- Pallor, lethargy, irritability, or poor feeding from anemia
- Fever or recurrent infections from low functional neutrophils
- Hepatosplenomegaly, an enlarged liver and spleen, often producing a distended abdomen
- Skin nodules, swollen lymph nodes, or, less often, neurological signs from central nervous system involvement
Infants often present with a very high white cell count, known as hyperleukocytosis, which carries its own risks of vessel blockage and metabolic complications at diagnosis.
Differential Diagnosis of Bruising in Infants
Babies who are not yet mobile rarely bruise. For that reason, unexplained bruising in a non-mobile infant raises two main concerns: a bleeding disorder, and non-accidental injury. Both need to be considered in parallel, and a normal blood count does not end the assessment. The table summarizes key distinctions.
| Cause | Typical features | Key initial tests |
|---|---|---|
| Leukemia | Petechiae, bruising, pallor, fever, hepatosplenomegaly, possible skin nodules | CBC with smear showing cytopenias and/or blasts |
| Immune thrombocytopenia (ITP) | Sudden petechiae and bruising in an otherwise well infant; often after a viral illness | Isolated low platelets; other counts normal |
| Neonatal alloimmune thrombocytopenia | Petechiae or bleeding in the first days of life in a well-appearing newborn | Low platelets; parental platelet antigen testing |
| Vitamin K deficiency bleeding | Bruising or bleeding in the first weeks, especially without vitamin K at birth | Prolonged PT; corrects with vitamin K |
| Hemophilia or other factor deficiency | Large bruises, bleeding after circumcision or injections; often a family history in males | Prolonged aPTT; specific factor levels |
| Non-accidental injury | Patterned bruises, bruises on ears, neck, or torso, inconsistent history | Normal coagulation screen; safeguarding assessment and skeletal survey as indicated |
| Congenital dermal melanocytosis | Flat blue-gray patches, often over the lower back, present from birth and unchanging | Clinical diagnosis; no bleeding tests needed |
Confirming the Diagnosis
A structured approach avoids both missed diagnoses and unnecessary procedures. Our general guide to diagnosing leukemia covers the adult pathway; in infants the steps are similar but interpreted against age-specific reference ranges.
- Complete blood count and peripheral smear: the key screening test. Leukemia typically shows low platelets and hemoglobin with an abnormal white count and circulating blasts.
- Coagulation screen: PT, aPTT, and fibrinogen to detect DIC or factor deficiencies.
- Bone marrow aspiration and biopsy: bone marrow aspiration and biopsy confirm the diagnosis and provide material for further testing.
- Flow cytometry: distinguishes acute lymphoblastic leukemia (ALL) from acute myeloid leukemia (AML) by cell surface markers.
- Cytogenetics and molecular tests: karyotype, FISH, and PCR identify rearrangements that define prognosis and treatment.
A hallmark of infant ALL is rearrangement of the KMT2A gene (formerly called MLL), which is found far more often in infants than in older children and is associated with more aggressive disease. Chronic forms of leukemia are exceptionally rare in this age group; chronic myeloid leukemia is mainly a disease of adults.
Treatment and Outlook
Treatment is delivered in specialist pediatric oncology centers. It typically follows the same phases used in older children, including induction to achieve remission, consolidation, and maintenance, but doses and supportive care are adapted to the infant’s immature organs. Because infant ALL with KMT2A rearrangement is high risk, some infants are offered hematopoietic stem cell transplantation in first remission, and targeted and immune-based treatments are being studied within clinical trials.
Bruising itself is managed by treating the leukemia and, where needed, with platelet transfusions for very low counts or active bleeding. For broader context on childhood disease, see our overviews of pediatric acute lymphoblastic leukemia and pediatric leukemia, as well as our leukemia guide.
When to See a Doctor
Parents and caregivers should seek same-day medical review if a baby has:
- Any bruise before the baby can crawl or pull to stand
- Petechiae or bruising together with fever, pallor, lethargy, or poor feeding
- A swollen abdomen, new skin lumps, or bleeding from the gums, nose, or umbilical stump
For clinicians, the practical rule is simple: unexplained bruising in a non-mobile infant needs a CBC, a coagulation screen, and a careful history, with safeguarding considered alongside hematologic causes. For more on symptom patterns, see our article on infant leukemia symptoms, diagnosis, and treatment.
Frequently Asked Questions
What do leukemia bruises look like on a baby?
They often look like ordinary bruises but appear without a clear bump, in unusual spots such as the back or chest, and may be accompanied by petechiae. Leukemia cutis can produce raised bluish or purple nodules that feel firm rather than flat.
Can a baby be born with leukemia?
Yes, though it is very rare. Congenital leukemia is present at or shortly after birth and may show skin nodules, an enlarged liver and spleen, and abnormal blood counts. Some newborns with Down syndrome have a related, often self-limiting condition called transient abnormal myelopoiesis.
Will a normal blood count rule out leukemia in an infant?
A completely normal CBC and smear make leukemia very unlikely. However, it does not explain the bruise, so other causes, including clotting disorders and injury, still need evaluation.
Why is infant leukemia treated differently from childhood leukemia?
Infant leukemia more often carries high-risk genetic changes such as KMT2A rearrangement, and infants tolerate chemotherapy differently. Treatment protocols are therefore adapted in both intensity and supportive care.
